Pharmacy Medical News about Raloxifene

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Optimized and validated spectrophotometric methods for the determination of raloxifene in pharmaceuticals using permanganate
Archives of Pharmacal Research, 10/14/09

Basavaiah K et al. – The proposed methods were applied to the commercially available tablets, and the results were statistically compared with those of the reference method. The accuracy and reliability of the methods were further ascertained by recovery studies.

<< Previous
Safety/Tolerability and Efficacy of Rivastigmine in Taiwanese...

Next >>
Two different approaches for the prediction of In Vivo plasma...

Raloxifene and body composition and muscle strength in postmenopausal women: A randomized, double-blind, placebo-controlled trial
European Journal of Endocrinology, 11/05/09 Relevance Score: 88%

Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast Cancer
Annals of Internal Medicine, 11/17/09 Relevance Score: 87%

Benefits and risks of raloxifene by vertebral fracture status
Current Medical Research and Opinion, 11/13/09 Relevance Score: 87%

Effects of raloxifene on the renin–angiotensin–aldosterone system and blood pressure in hypertensive and normotensive osteoporotic postmenopausal women
Geriatrics and Gerontology International, 10/12/09 Relevance Score: 87%

Raloxifene: its ossification-promoting effect on female mesenchymal stem cells
Journal of Orthopaedic Science, 10/08/09 Relevance Score: 87%